ASCO Recognizes Rep. Leonard Lance with Congressional Leadership Award

For immediate release
September 27, 2017

Contact

Rachel Martin
(571) 483-1383

ALEXANDRIA, Va. – The American Society of Clinical Oncology (ASCO) today presented Representative Leonard Lance (NJ-7) with its second annual Congressional Leadership Award in recognition of the lawmaker's exceptional commitment to supporting cancer research and treatment. The ASCO award honors a member of Congress who is a leading champion for patients and survivors of cancer, their families, and their cancer care teams.

"Since his election to Congress, Representative Lance has fought to advance legislation that improves research, treatment, and care for patients and survivors of cancer," said ASCO President Bruce E. Johnson, MD, FASCO, who presented the award. "We applaud Representative Lance's leadership and truly appreciate his hard work to support cancer-related policy priorities."

A member of the House Energy and Commerce Committee, Rep. Lance has worked diligently to ensure that all Americans have access to affordable, high-value cancer care, and that physicians are equipped to provide such care. He is the lead sponsor of the Cancer Drug Parity Act (H.R. 1409), legislation that will improve the affordability of oral cancer drugs for patients by ensuring they are covered in the same manner as intravenous chemotherapy.

Rep. Lance has shown his commitment to cancer research by supporting the 21st Century Cures Act, which provided a much-needed boost in supplemental funding to the National Institutes of Health (NIH) and the Food and Drug Administration (FDA) to support critical cancer research and accelerate the momentum of the Cancer Moonshot Initiative. He also supports the Childhood Cancer STAR Act (H.R. 820) to encourage more extensive research into childhood cancers. Rep. Lance is also co-leading a congressional sign-on letter to the Centers for Medicare & Medicaid Services urging them to stop a proposal that would threaten patient access to care by including Part B drugs in adjustments to practices under the new Merit-Based Incentive Payment System.

"The American Society of Clinical Oncology is a great partner to the doctors who treat patients facing cancer," said Representative Leonard Lance. "Cancer is a diagnosis no person wants to hear, but ASCO's members are the professionals cancer patients need in their corner. ASCO doctors have saved thousands of lives through cutting edge treatments and high quality care. They are the heroes of cancer care and I am pleased to be their partner in Washington on many important legislative priorities."   

Dr. Bruce Johnson presented the award to Rep. Lance during ASCO's Advocacy Summit, where ASCO volunteers from across the United States came to Capitol Hill to educate lawmakers about critical issues affecting patients with cancer and their providers. ASCO presented its first-ever Congressional Leadership Award to Rep. Michael Burgess, MD (TX-26) at last year's Advocacy Summit. 

About ASCO: 

Founded in 1964, the American Society of Clinical Oncology, Inc. (ASCO®) is committed to making a world of difference in cancer care. As the world’s leading organization of its kind, ASCO represents more than 40,000 oncology professionals who care for people living with cancer. Through research, education, and promotion of the highest-quality patient care, ASCO works to conquer cancer and create a world where cancer is prevented or cured, and every survivor is healthy. ASCO is supported by its affiliate organization, the Conquer Cancer Foundation. Learn more at www.ASCO.org, explore patient education resources at www.Cancer.Net, and follow us on Facebook, Twitter, LinkedIn, and YouTube.